series-b
Stage
2
Investors
About
Nodthera is a biotechnology company focused on developing medicines that inhibit the NLRP3 inflammasome to treat diseases.
Explore Nodthera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.